Macanda

The Macanda team is energized after a few intense and insightful days at ISPOR Europe in Barcelona. The impact of #AI, the #EUHTA regulation, and #RWE were the central themes of this year’s program and on-the-ground discussions. - The promise of AI continues to grow, but its practical implementation remains limited by challenges such as data confidentiality, data security, and output validity. Most stakeholders agree that in the coming years, supervised AI will make workflows more efficient, enabling us humans to explore new capabilities and expand the scope of what is possible. While the ISPOR presentations were often high-level, the practical use cases were a hot topic on the conference floor. - Unlike the AI sessions, several ISPOR workshops provided concrete examples of how RWE can be integrated into reimbursement applications. We are closely following developments in HTA-agency guidelines and staying updated on how European agencies approach RWE acceptance. - With the #JCA process set to begin in just two months, many stakeholders, including national agencies, are not fully prepared. Gaps in infrastructure and unresolved questions remain, underscoring the need for collaboration. We anticipate a phase of iteration and “learning by doing” to align processes effectively. While progress is evident, we had expected to see more concrete developments compared to last year’s conference. By next year’s ISPOR, we hope to look back at 2025 with hands-on learnings from the first JCA cases, a clear path forward, and new use cases for AI in health economics, real-world evidence, and market access workflows. The Macanda team is fully engaged in these transformative developments. Reach out to us at contact@macanda.se if you’d like to discuss the implications for your products and market access strategy in the Nordics. ⭐ ISPOR—The Professional Society for Health Economics and Outcomes Research #ISPOREurope #HTA

Exploring the Intersection of AI and Health Economics! This week, SHEA organised a seminar to discuss the different roles AI is beginning to play in healthcare, with a particular focus on health economics and health technology assessments. SHEA’s Asa By and Karolinska Institutet´s Linus Jönsson moderated sessions that brought together experts from Swedish healthcare, NICE - National Institute for Health and Care Excellence, academia, and industry. Key points related to health economics: 🔹 AI opens up opportunities for conducting systematic literature reviews and economic evaluations faster, more affordable, and potentially more comprehensive. 🔹 NICE is evaluating AI’s role in evidence generation for HTAs. They’ve issued a position statement (https://lnkd.in/dcxkMtAW), highlighting the importance of careful, transparent, standards-based implementation. NICE’s internal Innovation Lab case applications will explore adaptation and generation of health economic models. 🔹 Pharmaceutical companies are embracing AI across various stages of the life cycle, from identifying specific molecules during the R&D stage, to leveraging previous HTA learnings and crafting global value dossiers. To conclude, AI has potential to accelerate innovation and patients’ access to new products. However, with great potential comes great responsibility and the experts echoed the need for capable and informed human supervision. Health economists will be essential in guiding not only the development of new AI applications but also in ensuring that these applications complement and assist in delivering relevant evidence, as well as support transparent explanations of how the AI functions.

Our Asa By attended a seminar held by TOPRA - The Organisation for Professionals in Regulatory Affairs on EU HTA and early drug development last week. The discussions emphasized the importance of close collaboration between regulatory and health-economic teams from the outset. If you’d like to discuss these insights further, please reach out! #EUHTA #HealthEconomics

Welcome to Lise, We are pleased to welcome Lise Rumert as the newest addition to our team, stepping into the role of Office and HR administrator. Lise holds a Bachelor's degree in Pedagogy from Stockholms universitet, with a specialization in Human Resources, Work, and Organisation. With two years of experience in staffing, recruitment, and administration, she brings valuable expertise to support building a high-performing team, strengthen the Macanda culture and further develop our administrative platform. #Welcome #NewTeamMember #HR #ProjectSupport #TeamGrowth  

Last week, Macanda organised a traditional Swedish “surströmmingsskiva” (fermented herring). The participants consisted of colleagues from up north and a few(!) additional brave souls. #MarketAccess #HealthEconomics #HTA

Last week, the Macanda team set sail for a memorable kick-off in the Stockholm archipelago. It was the perfect blend of insightful workshops, team building, and a bit of adventure on the open water. We are now ready to channel this energy into the projects ahead! #MarketAccess #HEOR #Pharmaceuticals

Welcome to our newest team members at Macanda! We are excited to introduce two new recruits joining Macanda: Malin Gregorsson Edh and Hannes Hoppe. Malin joins as a consultant and operations manager, and brings over eight years of experience in market access across the Nordics. She joins us from Chiesi Pharma AB, where she held the role of Nordic Value & Access Manager, spearheading pricing and access strategies for rare and ultra-rare disease treatments. With six years of previous consulting experience, Malin has supported over 45 reimbursement projects and successfully managed complex, multi-national, multi-product projects. She holds a Master of Science in Bioentrepreneurship from Karolinska Institutet and a Bachelor of Science in Physiotherapy from Umeå universitet. Hannes joins us as a medical analyst with over six years of experience in medical biology, focusing on infectious diseases and cancer. He is nearing the completion of his PhD at Karolinska Institutet, where his research explores drug treatments for malaria. In addition, Hannes has RWE experience working with Nordic cancer registries. Hannes has a strong academic foundation with a BSc and MSc in biochemistry from The Martin Luther University of Halle-Wittenberg in Germany. We are thrilled to have Malin and Hannes on board. Their diverse backgrounds and experiences will help drive Macanda forward in making a difference in accelerating patient access to new valuable medical innovations. Join us in welcoming Malin and Hannes to the team! #NewTalent #MarketAccess #HealthEconomics

Last week, the Macanda team enjoyed a fantastic summer gathering in the Stockholm archipelago filled with great food and games. As we embrace the sunny days ahead, we wish everyone a joyful and relaxing summer!

Inspired by another good dialogue on the EU HTA Regulation's opportunities and challenges. Of course there are both. The national implementation is key, and we appreciate the hard work by stakeholders to strike a good balance. Niklas Hedberg, Helena Anderin, Oskar Ahlberg   A special thanks to Victri Advice and Jonas Vikman for hosting the seminar earlier this week, and for showing us Almedalen at its very best!   We also want to share a heads up on another interesting seminar at Almedalen: you can stream the discussion on our August Wadell Leimdörfer's research project on disease severity and willingness-to-pay thresholds tomorrow at 1 pm to 2pm. Link in the comments!

Macanda's August Wadell Leimdörfer was interviewed by the Economics Department at Uppsala universitet. An interesting read for those pursuing a career in health economics! #HealthEconomics #MarketAccess #HealthTechnologyAssessment